BioSpace News Archive

May 31, 2018 20:10 UTC TherapeuticsMD Announces Clinical Abstract at the 2018 ASCO Annual Meeting BOCA RATON, Fla.--( BUSINESS WIRE )-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced the availability of clinical data from the REJOICE trial for IMVEXXY™ (estradiol vaginal inserts) (formerly TX-004HR). TherapeuticsMD will highlight a substudy of the REJOICE trial that evaluated the

QIAGEN N.V. announced a partnership with Freenome, a leading artificial intelligence (AI) genomics company, to accelerate the development and commercialization of next-generation sequencing (NGS) tests to enable precision medicine in cancer treatment.

Agilent Technologies, Inc. announced that it has completed the acquisition of Advanced Analytical Technologies, Inc. (AATI).

Vaxart, Inc. announced that Roberto Mateo, Ph.D., lead scientist of Vaxart, will present data on the Phase 1 norovirus vaccine trial in a poster presentation at the American Society of Microbiology 2018.

The Canadian Medical Association (CMA) announces that MD Financial Management (MD) will be joining forces with Scotiabank to deliver premium services to all Canadian physicians and their families.

More than 550 children in 13 states and the District of Columbia received needed dental care at no cost during Kool Smiles’ 4th Annual Sharing Smiles Day, held Sunday, May 20, 2018.

Biostage, Inc. has elected Hong Yu as President, effective May 29, 2018.

- The Daratumumab neutralization testing service from Grifols, will allow improved management of patients under Daratumumab treatment requiring transfusion - Test will be offered at Grifols Immunohematology Center in San Marcos, Texas

Partnership with Hitachi Ltd. Ushers In Next-Evolution Ultrasound Processor; Provides Endoscopists with a Greater Depth of Information

Colon cancer is the third deadliest form of cancer in men and women, and according to the American Cancer Society, people need to start getting screened sooner.